Remdesivir-bisPropionate, a better derivative of remdesivir against SARS-CoV-2: Comparison of in vitro and in vivo PK/PD Study as well as its therapeutic potential - Ashok Chakraborty; Anil Diwan; Vijetha Chiniga; Vinod Arora; Yogesh Thakur; Jayant Tatake; Rajesh Pandey; Preetam Holkar; Neelam Holkar (PLoS ONE, 2026)